Navigation Links
JMAR Technologies' Chief Scientist Invited by Pfizer Inc. to Speak at IFPAC -- BioSentry Makes Strides in Pharma Market
Date:1/28/2009

JMAR Technologies, Inc. (OTCBB: JMAR), a leading innovator in the development and commercialization of sensing systems for the detection of chemical, biological, radiological, nuclear and explosive (CBRNE) materials, today announced that JMAR's microbial contamination detection expert John A. Adams, Ph.D. will be speaking at the 2009 International Foundation Process Analytical Chemistry (IFPAC) annual meeting on Wednesday, January 28, 2009, in Baltimore, Maryland.

San Diego (Vocus) January 28, 2009 -- JMAR Technologies, Inc. (OTCBB: JMAR), a leading innovator in the development and commercialization of sensing systems for the detection of chemical, biological, radiological, nuclear and explosive (CBRNE) materials, today announced that JMAR's microbial contamination detection expert John A. Adams, Ph.D. will be speaking at the 2009 International Foundation Process Analytical Chemistry (IFPAC) annual meeting on Wednesday, January 28, 2009, in Baltimore, Maryland.

The IFPAC annual meeting, combining industry leaders and research institutions with officials from the U.S. Food and Drug Administration (FDA), focuses on the latest developments in emerging technologies: Process Analytical Technology (PAT), Quality by Design (QbD), and Real-Time Analytics. Dr. Adams was invited by Pfizer to present "Automated Real-Time On-Line Measurement of Bacteria in Water using Multi-Angle Light Scattering (MALS) Techniques." JMAR successfully uses MALS technology in its award-winning, laser-based BioSentry® product, the only commercialized, EPA tested, online system for real-time detection of microbial contamination in water.

BioSentry® satisfies the need for rapid, real-time microbial detection in pharmaceutical processing. Immediate detection and classification integrates true quality control into process water by constantly monitoring for biological contaminants that could result in the loss of product, manufacturing recalls, and potential liability for consumer illness.

"We are honored to have this opportunity to showcase BioSentry® as a Rapid Microbiological Method in pharmaceutical manufacturing," said JMAR's Chief Executive Officer, C. Neil Beer, Ph.D. "BioSentry® can be used as both a real-time contamination alarm and as a biological monitoring device to complement and enhance the water quality safeguards used by the pharmaceutical industry today."

Frost & Sullivan recognized JMAR's BioSentry® as the leading innovative approach to water quality monitoring in their 2008 Biological Detection Product of the Year Award.

To be added to JMAR Technologies' investor lists, please contact Haris Tajyar at 818-382-9702.

To see a video presentation about JMAR's BioSentry®, visit http://video.google.com/videoplay?docid=-684619603716680223

About JMAR

Coupled with its established expertise in building advanced laser systems, JMAR provides solutions for a broad range of military, industrial and commercial applications. The Company draws on more than twenty years of experience and twenty-nine patents and patents pending in photonics, laser and detection technologies to develop products and solutions that address some of the world's most pressing issues such as water quality, hazard detection and homeland security. JMAR's vision is to continue to develop innovative technologies and products that support the advancement of global health, safety, and security initiatives. For further information on JMAR Technologies, please visit http://www.jmar.com.

About IFPAC

The International Foundation Process Analytical Chemistry is a world-wide, not-for-profit organization dedicated to the advancement of Process Analytical Technology and Chemistry. It provides a platform for the interaction of ideas and sharing of information among industry, research institutions, government agencies, and the manufacturers and suppliers of Process Analytical Chemistry and Technology. IFPAC's ultimate goal is to understand and ensure quality control in the manufacturing process. The organization promotes and advances the key components and benefits of innovative manufacturing and continuous quality assurance.

Forward Looking Statements: This news release contains certain "forward-looking statements." Forward-looking statements are based on current expectations and assumptions and are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, and many of which are beyond the Company's control. Actual results could differ materially from these forward-looking statements as a result of a number of factors, including the uncertainty of acceptance in the market for our products and technologies or the acceptance of our customers' products or technologies which incorporate our products and technologies, the failure of our technology to perform as predicted, competition from alternative technologies, uncertainties as to the size of the markets, cost and margins for JMAR's products, current or future government regulations affecting the use of JMAR's products, the lack of availability of critical components, the degree of protection from future patents, other risks associated with the development or acquisition of new products or technologies and those risks detailed in the Company's Form 10-K for the year ended December 31, 2007 filed with the SEC. Given these risks and uncertainties, investors are cautioned not to place undue reliance on such forward-looking statements and no assurances can be given that such statements will be achieved. JMAR Technologies, Inc. does not assume any duty to publicly update or revise the material contained herein.

# # #

Read the full story at http://www.prweb.com/releases/2009/01/prweb1929044.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Amylin Pharmaceuticals Appoints Vincent Mihalik Senior Vice President, Sales and Marketing and Chief Commercial Officer
2. Dr. Steven L. Zelenkofske Joins Regado Biosciences as Senior Vice President, Clinical and Medical Affairs and Chief Medical Officer
3. PAREXEL Appoints Josephine Hoppe to Chief Information Officer
4. Cequent Names Ted Hibben Chief Business Officer
5. Agendia Appoints New Chief Financial Officer
6. Kiadis Pharma Appoints Dr. Maarten Egeler, MD PhD as Chief Medical Officer
7. Epitomics Appoints Dr. Zhiqiang An as Chief Scientific Officer
8. Algeta Appoints Andrew Kay as President and Chief Executive Officer
9. Interface Biologics secures $5mm financing and appoints Thomas P. Reeves President and Chief Executive Officer
10. AstraZeneca Appoints Graham Baker Vice President and Chief Financial Officer for North America
11. Histogen Welcomes Dr. Hyma Gollamudi as Chief Business Officer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
JMAR Technologies' Chief Scientist Invited by Pfizer Inc. to Speak at IFPAC -- BioSentry Makes Strides in Pharma Market
(Date:6/27/2016)... , June 27, 2016   Ginkgo Bioworks ... to industrial engineering, was today awarded as one ... selection of the world,s most innovative companies. Ginkgo ... scale for the real world in the nutrition, ... engineers work directly with customers including Fortune 500 ...
(Date:6/24/2016)... June 24, 2016 Epic Sciences unveiled ... cancers susceptible to PARP inhibitors by targeting homologous ... (CTCs). The new test has already been incorporated ... multiple cancer types. Over 230 clinical ... response pathways, including PARP, ATM, ATR, DNA-PK and ...
(Date:6/24/2016)... ... 24, 2016 , ... Researchers at the Universita Politecnica delle Marche in Ancona ... or pleural mesothelioma. Their findings are the subject of a new article on the ... are signposts in the blood, lung fluid or tissue of mesothelioma patients that can ...
(Date:6/23/2016)... ... 2016 , ... UAS LifeSciences, one of the leading manufacturers ... Probiotics, into Target stores nationwide. The company, which has been manufacturing high quality ... list of well-respected retailers. This list includes such fine stores as Whole Foods, ...
Breaking Biology Technology:
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com , ... published the overview results from the Q1 wave of ... recent wave was consumers, receptivity to a program where ... with a health insurance company. "We were ... share," says Michael LaColla , CEO of Troubadour ...
(Date:5/3/2016)... May 3, 2016  Neurotechnology, a provider of ... MegaMatcher Automated Biometric Identification System (ABIS) , a ... projects. MegaMatcher ABIS can process multiple complex biometric ... combination of fingerprint, face or iris biometrics. It ... and MegaMatcher Accelerator , which have ...
(Date:4/28/2016)... 2016 First quarter 2016:   ... with the first quarter of 2015 The gross margin ... (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... unchanged, SEK 7,000-8,500 M. The operating margin for 2016 ...
Breaking Biology News(10 mins):